Valuation : GC Genome Corporation

Market Cap 13TCr 9.8Cr 8.46Cr 7.97Cr 7.26Cr 14Cr 926.16Cr 14Cr 94Cr 37Cr 473.52Cr 37Cr 36Cr 1.56TCr P/E 2026 *
-
P/E 2027 * -
Enterprise Value 7.38Cr 54.31T 46.85T 44.13T 40.21T 75.16T 51.3L 75.72T 5L 2L 26.23L 2L 2L 86.16L EV / Sales 2026 *
1.89x
EV / Sales 2027 * 1.32x
Free-Float
49.55%
Yield 2026 *
-
Yield 2027 * -
1 day-4.41%
1 week+1.44%
Current month-4.90%
1 month+22.39%
3 months+0.90%
6 months-31.59%
Current year-17.45%
1 week 5,520
Extreme 5520
5,970
1 month 4,865
Extreme 4865
6,050
Current year 4,100
Extreme 4100
9,520
1 year 4,100
Extreme 4100
9,520
3 years 4,100
Extreme 4100
15,180
5 years 4,100
Extreme 4100
15,180
10 years 4,100
Extreme 4100
15,180
Manager TitleAgeSince
Chief Executive Officer 57 26/03/2020
Director of Finance/CFO 50 27/03/2025
Comptroller/Controller/Auditor 45 29/03/2024
Director TitleAgeSince
Director/Board Member 57 30/03/2023
Date Insider Type Main position Quantity % Market Cap. Importance
17/06/25 Free

Chief Executive Officer

1,69,285 -
17/06/25 Free 1,38,250 --
Change 5-day change 1-year change 3-year change Capi.($)
-4.41%+1.44%-23.92% - 10Cr
+1.37%-3.93%+92.02%+420.10% 4.62TCr
+1.24%-1.21%+21.14%+60.55% 2.66TCr
-0.45%-7.21%-17.99%-41.94% 694.39Cr
+0.24%-1.01%+7.67%+132.42% 594.32Cr
+0.61%+0.13%+17.12%+74.09% 335.23Cr
+2.25%-3.95%-32.35%+1,829.25% 252.92Cr
-0.29%+0.17%+97.50%+14.70% 224.19Cr
+5.30%+4.96%+27.73%+33.27% 202.9Cr
-2.60%-5.64%-13.69%-55.31% 188.3Cr
Average +0.33%-1.44%+17.52%+274.13% 978.29Cr
Weighted average by Cap. +1.10%-3.45%+50.69%+270.13%

Financials

2026 *2027 *
Net sales 3.9TCr 2.87Cr 2.48Cr 2.33Cr 2.13Cr 3.97Cr 271.27Cr 4Cr 28Cr 11Cr 138.69Cr 11Cr 11Cr 455.59Cr 4.88TCr 3.59Cr 3.1Cr 2.92Cr 2.66Cr 4.97Cr 339.43Cr 5.01Cr 35Cr 13Cr 173.54Cr 13Cr 13Cr 570.08Cr
Net income - -
Net Debt -5.94TCr -4.37Cr -3.77Cr -3.55Cr -3.24Cr -6.05Cr -413.16Cr -6.1Cr -42Cr -16Cr -211.24Cr -16Cr -16Cr -693.9Cr -6.88TCr -5.07Cr -4.37Cr -4.12Cr -3.75Cr -7.01Cr -478.54Cr -7.06Cr -49Cr -19Cr -244.66Cr -19Cr -19Cr -803.71Cr
Logo GC Genome Corporation
GC Genome Corp is a Korea-based company principally engaged in the provision of genome testing and analysis services. The Company is principally engaged in the provision of prenatal and newborn screening genetic testing services, cancer patient precision diagnosis genetic testing services, precision diagnosis genetic testing service for patients with rare diseases, health checkup test services as well as others.
Employees
-
Date Price Change Volume
02/26/02 ₩5,630.00 -4.41% 45,383
01/26/01 ₩5,890.00 -0.51% 32,139
31/26/31 ₩5,920.00 -0.84% 69,081
28/26/28 ₩5,970.00 +6.61% 90,451
27/26/27 ₩5,600.00 +0.90% 1,34,911

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A340450 Stock